Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Apr 2, 2018, during market hours
10-K filed Apr 2, 2018, 92 days after period end · 0001171843-18-002404
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $252.50K | $8.75K | $2.50K | $4.67K |
| Net Income | -$3.32M | -$5.40M | -$4.77M | -$5.50M |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| EPS Diluted |
|---|
| — |
| — |
| -$0.05 |
| -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
